JC
Insider
Jack W Callicutt
Chief Financial OfficerJack W Callicutt (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $407K of GALT (66,011 sh across 3 lots, as filed), executed Nov 17 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$507K
shares × price, as filed
Last traded
Jan 5
Filed Jan 6
Median ADV $2.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $507K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
GALTRecent filings
GALTSALE
Galectin Therapeutics Inc.
View filing →
$100K25,732 sh × $3.90
Exec Jan 5
Filed Jan 6 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. View filing → $407K
66,011 sh across 3 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET